Bradley L. Campbell is CEO & President at AMICUS THERAPEUTICS, INC. (FOLD). They have made 39 open-market trades across 1 company since 2014, most recently 2026-03-02.
CIK 0001400971
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases totalling $201K since 2014, against 39 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FOLD | 998,680 | $14.5M |
| PGNX | 12,000 | $49K |
| Total | $14.5M |
Shares reported on the most recent Form 4, priced at the 2026-03-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FOLD | SELL · 10b5-1 | 2026-03-02 | 2026-03-04 | $14.35 | $323K | +0.3% | +0.8% | N/A |
| FOLD | SELL | 2026-01-20 | 2026-01-22 | $14.31 | $1.1M | +0.1% | +0.6% | +1.4% |
| FOLD | SELL · 10b5-1 | 2025-12-15 | 2025-12-17 | $10.86 | $1.7M | +30.0% | +30.7% | +31.2% |
| FOLD | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $10.01 | $292K | +12.5% | +47.6% | +48.3% |
| FOLD | SELL · 10b5-1 | 2025-11-24 | 2025-11-26 | $10.04 | $293K | -1.8% | +42.6% | +43.7% |
| FOLD | SELL · 10b5-1 | 2025-02-19 | 2025-02-21 | $10.00 | $4K | -0.1% | -5.1% | -31.7% |
| FOLD | SELL · 10b5-1 | 2024-12-02 | 2024-12-03 | $10.02 | $75K | -4.5% | -5.0% | -6.8% |
| FOLD | SELL · 10b5-1 | 2024-11-06 | 2024-11-07 | $12.50 | $198K | -13.5% | -10.6% | -11.1% |
| FOLD | SELL · 10b5-1 | 2024-11-01 | 2024-11-04 | $11.46 | $86K | -10.2% | -12.3% | -14.2% |
| FOLD | SELL · 10b5-1 | 2024-10-01 | 2024-10-04 | $10.60 | $80K | -0.8% | +7.0% | -12.1% |
| FOLD | SELL · 10b5-1 | 2024-09-03 | 2024-09-05 | $11.71 | $88K | -6.0% | -14.2% | -17.2% |
| FOLD | SELL · 10b5-1 | 2024-08-01 | 2024-08-05 | $10.34 | $78K | +19.5% | +20.3% | +18.3% |
| FOLD | SELL · 10b5-1 | 2024-07-05 | 2024-07-09 | $10.00 | $61K | +0.3% | +9.4% | -1.3% |
| FOLD | SELL · 10b5-1 | 2024-07-01 | 2024-07-03 | $10.00 | $14K | +10.8% | +3.1% | +9.0% |
| FOLD | SELL · 10b5-1 | 2024-06-03 | 2024-06-05 | $10.00 | $75K | -3.5% | -3.7% | +11.8% |
| FOLD | SELL · 10b5-1 | 2024-05-01 | 2024-05-03 | $10.07 | $76K | -7.0% | -3.5% | -1.8% |
| FOLD | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $11.67 | $88K | -6.7% | -9.0% | -13.8% |
| FOLD | SELL · 10b5-1 | 2024-03-01 | 2024-03-05 | $13.14 | $416K | -14.9% | -15.0% | -25.6% |
| FOLD | SELL · 10b5-1 | 2024-02-15 | 2024-02-20 | $14.00 | $58K | -1.8% | -13.6% | -27.9% |
| FOLD | SELL · 10b5-1 | 2024-02-01 | 2024-02-05 | $12.56 | $398K | +11.0% | -0.1% | -18.0% |
| FOLD | SELL · 10b5-1 | 2024-01-02 | 2024-01-04 | $14.23 | $344K | -3.6% | -4.7% | -14.6% |
| FOLD | SELL · 10b5-1 | 2023-12-01 | 2023-12-05 | $11.08 | $259K | +13.7% | +20.1% | +20.3% |
| FOLD | SELL · 10b5-1 | 2023-11-01 | 2023-11-03 | $10.97 | $257K | -7.6% | -3.8% | +9.8% |
| FOLD | SELL · 10b5-1 | 2023-10-02 | 2023-10-04 | $11.22 | $257K | -1.9% | +7.6% | +32.3% |
| FOLD | SELL · 10b5-1 | 2023-09-01 | 2023-09-06 | $12.97 | $469K | +1.4% | -12.8% | -12.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.